FindTrial
Sign In

Double Umbilical Cord blood stem cell transplantation for the treatment of adults with hematologic malignancies

Double Umbilical Cord blood stem cell transplantation for the treatment of adults with hematologic malignancies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16008829
Enrollment
Unknown
Registered
2016-07-12
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic malignancies

Interventions

Case series:Nil

Sponsors

Zhongda Hospital, Medical School, Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged 10-50 years old; 2. comply with allogeneic hematopoietic stem cell transplantation indications; 3. No compatriots consistency but in urgent need of HLA matching patients to transplant; 4. No serious liver, kidney and other organ damage patients; 5. ECOG=3.

Exclusion criteria

Exclusion criteria: 1. Serious neurological and psychiatric history; 2. extreme physical weakness expected survival <3 months; 3. with severe cardiovascular and lung, liver and kidney dysfunction; 4. uncontrollable infection; 5. No indications for transplantation.

Design outcomes

Primary

MeasureTime frame
disease-free survival, overall survival and recurrence and prognosis of transplant-related mortality and survival;—

Countries

China

Contacts

Public ContactZhengping Yu

Affiliated Zhongda Hospital Medical College of Southeast University

zhengpingyu2006@sina.com+86 15951946338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026